feed,title,long_url,short_url
Benzinga,Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward,https://benzinga.com/general/biotech/22/02/25419181/valneva-pfizer-choose-three-dose-schedule-for-lyme-vaccine-candidate-moving-forward,https://bit.ly/34yc9ay
Benzinga,Delcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To Liver,https://benzinga.com/general/biotech/22/02/25419639/delcaths-chemosat-hepatic-delivery-system-shows-overall-response-rate-of-60-5-in-eye-cancer-that-,https://bit.ly/3GtkidB
